Astrana Health, Inc. (NASDAQ:ASTH) Q1 2024 Earnings Conference Call May 7, 2024 5:30 PM ET
Company Participants
Brandon Sim - President & Chief Executive Officer
Chan Basho - Chief Operating & Financial Officer.
Conference Call Participants
Ryan Daniels - William Blair
David Larsen - BTIG
Adam Ron - Bank of America
Jack Slevin - Jefferies
Jailendra Singh - Truist Securities
Christian Borgmeyer - TD Securities
Operator
Good day everyone and welcome to today's Astrana Health First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Today's speaker would be Brandon Sim, President and Chief Executive Officer of Astrana Health; and Chan Basho, Chief Operating and Financial Officer.
A press release announcing Astrana Health Inc.'s results for the first quarter ended March 31, 2024 is available at the Investors section of the company's website at www.astranahealth.com. The company will discuss certain non-GAAP measures during this call. Reconciliations to the most comparable GAAP measure are included in the press release. To provide some additional background on its results, the Company has made a supplemental deck available on its website. A replay of this broadcast will also be made available at Astrana Health website after the conclusion of this call.
Before we get started, I would like to remind everyone that this conference call and any accompanying information discussed herein contains certain forward-looking statements within the meaning of the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terms such as anticipate, believe, expect, future, plan, outlook and will and include among other things statements regarding the company's guidance for the year ending December 31, 2024, continued growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans and merger integration efforts.
- Read more current ASTH analysis and news
- View all earnings call transcripts